Merck eyes global innovation hubs, preps for sale of drugs
This article was originally published in Scrip
Executive Summary
Merck & Co is shaking up its R&D operations even further and plans innovation centers to gain new research as the company also prepares to sell some of its own drugs in development, the Wall Street Journal reported.